References
- Cai D, Li Y, Zhou C, et al. Comparative proteomics analysis of primary cutaneous amyloidosis. Exp Ther Med. 2017;14:3004–3012.
- Weinder T, Illing T, Elsner P. Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol. 2017;18:625–642.
- Barsky M, Buka RL. Pulsed dye laser for the treatment of macular amyloidosis: a case report. Cutis. 2014;93:189–192.
- Ostovari N, Mohtasham N, Oadras MS. Malekzad F. 532nm and 1064-nm Q-switched Nd-YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J EUR Acad Dermatol Venerol. 2008;22:442–446.
- Khurana N, Urman C. The efficacy of Q-Switched ND:YAG 1064 nm laser in recalcitrant macular amyloidosis: a case report. J Drugs Dermatol. 2016;15:1456–1458.
- Yahya RS. Treatment of primary cutaneous amyloidosis with lasers: a review of the literature. lasers Med Sci. 2016;31:1027–1035.
- Chu H, Shin JU, Lee J, et al. Successful treatment of lichen amyloidosis accompanied by atopic dermatitis by fractional CO2 laser. J Cosmet Laser Ther. 2017;19:345–346.
- Esmat SM, Fawzi MM, Gawdat HI, et al. Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers surg Med. 2015;47:388–395.